MALVERN, PA — Dr. Shankar Musunuri, Chairman and CEO of Ocugen, Inc. (NASDAQ: OCGN), is set to join a panel discussion at the upcoming 2024 Maxim Healthcare Virtual Summit. Scheduled from October 15 to October 17, the summit is organized by Maxim Group LLC and serves as a platform for discussing advancements in the healthcare industry.
Dr. Musunuri will participate in the Ocular Drug Development panel on Tuesday, October 15, from 11 a.m. to noon EDT. The panel will focus on innovations in vision enhancement, disease modification, and restoration techniques. It will feature companies at the forefront of ocular therapies in mid-to-late-stage development.
Expressing enthusiasm about the event, Dr. Musunuri stated, “The Maxim Healthcare Virtual Summit is a new opportunity for Ocugen.” He is eager to present Ocugen’s pioneering modifier gene therapy platform to a distinguished group of investors.
The summit promises to be an engaging event, featuring a wide range of biotechnology, diagnostic, and medical device companies. Senior analysts from Maxim will facilitate interactive discussions with CEOs and management teams, along with several industry panels that explore current and relevant healthcare topics.
For the latest news on everything happening in Chester County and the surrounding area, be sure to follow MyChesCo on Google News and MSN.